Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

283 (9%)

Anticipated shortage:

1 (0%)

Avoided shortage:

10 (0%)

Resolved:

2953 (91%)

3247

Discontinuation Reports

To be discontinued:

2 (0%)

Discontinued:

410 (94%)

Reversed:

23 (5%)

435

483 (13%)

16 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
NOVO-HYDROXYZIN 50MG CAPSULE Actual shortage 2017-03-13 2020-02-13 1017
NOVO-HYDROXYZIN 25MG CAPSULE Actual shortage 2017-03-13 2017-10-05 1013
NOVO-HYDROXYZIN 10MG CAPSULE Actual shortage 2017-03-10 2017-10-05 159
NOVO-MYCOPHENOLATE 250MG CAPSULE Resolved 2017-03-14 2017-04-25 2278
NOVO-PROFEN 400MG TABLET Resolved 2018-03-13 2018-05-30 42644
NV-CLINDAMYCIN 150MG CAPSULE Resolved 2025-10-01 2025-10-01 268159
NV-CLINDAMYCIN 150MG CAPSULE Resolved 2021-03-11 2021-04-29 135561
NV-CLINDAMYCIN 150MG CAPSULE Resolved 2020-09-24 2020-10-08 124959
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2024-10-11 2024-11-08 240046
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2024-10-17 2025-01-30 240525
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2024-11-28 2025-05-30 244081
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2022-08-18 2024-06-13 166975
OCTREOTIDE FOR INJECTABLE SUSPENSION 20MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2022-08-18 2024-06-13 166972
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2022-08-18 2024-06-17 166969
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2025-07-29 2025-08-29 263746
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, EXTENDED-RELEASE KIT Resolved 2022-03-04 2022-03-24 156070
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2025-09-19 2025-12-18 267502
OCTREOTIDE FOR INJECTABLE SUSPENSION 20MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2025-12-18 2025-12-18 274590
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2025-12-18 2025-12-18 274595
OCTREOTIDE FOR INJECTABLE SUSPENSION 20MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2025-01-09 2025-11-06 247309
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT ENALAPRIL 4MG TABLET Discontinued 2025-05-28 2025-05-28 258682
ACT ENALAPRIL 8MG TABLET Discontinued 2025-05-28 2025-05-28 258676
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64529
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64532
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64535
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64520
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64526
ACT ETIDROCAL 400MG 500MG TABLET Discontinued 2019-02-21 2019-03-01 76486
ACT FLUCONAZOLE 50MG TABLET Discontinued 2025-05-28 2025-05-28 258697
ACT FLUCONAZOLE 100MG TABLET Discontinued 2025-05-28 2025-05-28 258703
ACT LEVETIRACETAM 500MG TABLET Discontinued 2020-01-24 2020-01-24 104304
ACT LEVOFLOXACIN 250MG TABLET Discontinued 2025-09-02 2025-09-02 266377
ACT LEVOFLOXACIN 750MG TABLET Discontinued 2025-09-02 2025-09-02 266383
ACT LEVOFLOXACIN 500MG TABLET Discontinued 2025-09-02 2025-09-02 266380
ACT NABILONE 0.5MG CAPSULE Discontinued 2021-09-23 2021-09-23 146066
ACT NABILONE 1MG CAPSULE Discontinued 2019-10-31 2019-11-01 97581
ACT NABILONE 0.5MG CAPSULE Discontinued 2020-10-15 2020-10-15 126452
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Discontinued 2020-01-24 2020-01-24 104277
ACT OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2019-10-25 2019-10-26 97256
ACT OLMESARTAN 40MG TABLET Discontinued 2020-06-11 2020-06-11 117500

Showing 21 to 40 of 435